Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Batchelor

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Science Translational Medicine|January 13, 2012
Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopyOvidiu C Andronesi, Grace S Kim, Elizabeth Gerstner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasHoward A Fine, Patrick Y Wen, Elizabeth A Maher, et al.
Neuro-Oncology Practice|June 9, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastomaJohn Y Rhee, Carissa Mastrangelo, Paul J Miller, et al.
Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002Andrés J M Ferreri, Lauren E Abrey, Jean-Yves Blay, et al.
Journal of Neuro-Oncology|May 8, 2010
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasDavid M Peereboom, Jeffrey G Supko, Kathryn A Carson, et al.
Cancer|April 21, 2012
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)L Burt Nabors, Thomas Mikkelsen, Monika E Hegi, et al.
Neuroimage|February 2, 2025
Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imagingPaul J Weiser, Georg Langs, Wolfgang Bogner, et al.
Blood|January 19, 2006
Gene expression and angiotropism in primary CNS lymphomaJames L Rubenstein, Jane Fridlyand, Arthur Shen, et al.
Translational Oncology|June 10, 2015
Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma PatientsKourosh Jafari-Khouzani, Kyrre E Emblem, Jayashree Kalpathy-Cramer, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Science Translational Medicine|January 13, 2012
Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopyOvidiu C Andronesi, Grace S Kim, Elizabeth Gerstner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasHoward A Fine, Patrick Y Wen, Elizabeth A Maher, et al.
Neuro-Oncology Practice|June 9, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastomaJohn Y Rhee, Carissa Mastrangelo, Paul J Miller, et al.
Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002Andrés J M Ferreri, Lauren E Abrey, Jean-Yves Blay, et al.
Journal of Neuro-Oncology|May 8, 2010
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasDavid M Peereboom, Jeffrey G Supko, Kathryn A Carson, et al.
Cancer|April 21, 2012
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)L Burt Nabors, Thomas Mikkelsen, Monika E Hegi, et al.
Neuroimage|February 2, 2025
Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imagingPaul J Weiser, Georg Langs, Wolfgang Bogner, et al.
Blood|January 19, 2006
Gene expression and angiotropism in primary CNS lymphomaJames L Rubenstein, Jane Fridlyand, Arthur Shen, et al.
Translational Oncology|June 10, 2015
Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma PatientsKourosh Jafari-Khouzani, Kyrre E Emblem, Jayashree Kalpathy-Cramer, et al.
Pageof 6